Pakistan’s biggest pharma deal in advanced talks: report
Businessman Munis Abdulla to purchase one of OBS Group's pharmaceutical operations for a reported sum of Rs11bn
Pakistan's OBS Group is in advanced talks...
Citi Pharma gets FDA nod to start exporting nutraceuticals to the United States
The pharmaceutical ingredients manufacturer enters the consumer-facing market in the US with a product the US regulator classifies as food, and not drugs
Pharma industry protests govt’s refusal to increase drug prices
LAHORE: The Ministry of National Health Service Regulations and Coordination on Monday announced that there will be no immediate increase in drug prices prompting...
Pakistan loses up to Rs50bn annually to unethical drug marketing, say DRAP officials
DRAP CEO says irrational drug use accounts for nearly a quarter of Pakistan’s total health budget and is accelerating antimicrobial resistance
DRAP to establish ‘Code of Ethics’ for doctors and pharma companies
Karachi: Drug Regulation Authority of Pakistan (DRAP) is planning to establish a much needed ‘Code of Ethics’ for doctors and pharmaceutical companies, which would...
Macter gaining market share, and diversifying into cosmetics
The biopharmaceutical manufacturer saw revenue growth faster than industry average, and also plans to launch a GLP 1 product
Lucky Core seals deal for Pfizer’s Karachi plant, pharma products
Asset Purchase Agreements signed, acquisition includes products such as Ansaid, Ponstan, Ponstan Forte, Basoquin, Deltacortril, Lysovit, Corex-D, and Mycitracin.
Saudi investors exit Pakistan’s largest pharmacy chain. What happened and why?
From its origins as part of the Servis Group to multiple changes in ownership since its inception in 2005, Servaid has undergone an eventful two decades in existence
Lucky Core Industries expands portfolio with Pfizer assets acquisition
Deal includes a manufacturing facility, certain pharma products and trademarks associated with said products
Pakistan’s retail pharma sector surpasses Rs1.049 trillion in sales
Data from IQVIA reveals steep price hikes drive growth as medicine consumption shows minimal increase, raising concerns over affordability
Pakistan to import insulin from Russia through pharmaceutical joint ventures
Joint ventures to strengthen insulin supply, with focus on local manufacturing and price regulation
Drug price deregulation has come to Pakistan. What will this mean?
Companies can finally raise prices, which is likely to result in higher prices, but also likely to mean fewer shortages of essential drugs
Citi Pharma submits offers for acquisition of leading pharma company
Non-binding offer is part of Citi’s strategic expansion plans to become largest pharma firm
Citi Pharma completes first export to MENA region, targets EUR 10 million in annual global sales
Finalizes EUR 560,000 shipment; aims to expand exports to North America and beyond
Customs seizes smuggled Indian-origin medicines worth Rs10.3bn in Karachi
Investigation launched against two pharmaceutical companies over illegal drug trade
